Connect with us

Drugmakers Race to Develop More Convenient Weight Loss Pills

 
weight loss pills

Credit: Envato Elements

The weight loss drug market is on the verge of a major innovation as several drugmakers race to develop effective, convenient, and potentially affordable obesity pills.

Currently, most weight loss and diabetes drugs, such as Novo Nordisk’s Wegovy and Ozempic and Eli Lilly’s Zepbound and Mounjaro, are administered as weekly injections. These medications are GLP-1 agonists, which have seen a surge in popularity over the past year.

Now, major players like Novo Nordisk, Eli Lilly, and Pfizer, along with other drugmakers such as Roche and AstraZeneca, are working on oral alternatives that promise greater convenience for patients and easier large-scale manufacturing. This development could also address the supply shortages currently affecting injectable treatments in the U.S.

Read more